Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of conformational epitopes of pemphigus vulgaris antigen (Dsg3)

Journal of Investigative Dermatology

Volumn 107, Issue 4, 1996, Pages 539-542

  Amagai, Masayuki ^a   Ishii, Ken ^a   Takayanagi, Atsushi ^a   Nishikawa, Takeji ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; Baculovirus expression; Cadherin; Desmoglein

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 10A;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

EID: 0029797655     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12582796     Document Type: Article

References (16)

1. Amagai M: Adhesion molecules. I. Keratinocyte-keratinocyte interactions, cadherins and pemphigus. J Invest Dermatol 104:146-152, 1995
2. Amagai M: Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 11:319-352, 1996
3. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T: Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 104:895-901, 1995a
4. Amagai M, Hashimoto T, Shimizu N, Nishikawa T: Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 94:59-67, 1994
5. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T: Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 105:243-247, 1995b
6. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR: Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 90:919-926, 1992
7. Amagai M, Klaus-Kovtun V, Stanley JR: Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-877, 1991
8. Amagai M, Koch PJ, Nishikawa T, Stanley JR: Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 106:351-355, 1996
9. Eyre RW, Stanley JR: Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 81:807-812, 1988
10. Kozak M: An analysis of 5′-coding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148, 1987
11. Neurath H: Proteolytic processing and physiological regulation. Trends Biochem Sci 14:268-271, 1989
12. Ozawa M, Kemler R: Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol 111:1645-1650, 1990
13. Rapoport TA: Transport of proteins across the endoplasmic reticulum membrane. Science 258:931-936, 1992
14. Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53:291-325, 1993
15. Stanley JK, Yaar M, Hawley NP, Katz SI: Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 70:281-288, 1982
16. von Heijne G: Protein targeting signals. Can Opin Cell Biol 2:604-608, 1990